BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 10:13:33 AM | Browse: 636 | Download: 358
Publication Name World Journal of Diabetes
Manuscript ID 29158
Country/Territory Australia
2016-07-31 12:52
Peer-Review Started
2016-08-01 22:00
To Make the First Decision
2016-10-20 08:40
Return for Revision
2016-10-20 14:37
2016-11-07 13:23
Second Decision
2017-03-07 15:26
Accepted by Journal Editor-in-Chief
2017-03-07 17:34
Accepted by Company Editor-in-Chief
2017-03-17 14:01
Articles in Press
2017-03-17 14:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-05-09 14:33
Publish the Manuscript Online
2017-05-15 10:13
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Minireviews
Article Title Effects of glycaemic management on diabetic kidney disease
Manuscript Source Invited Manuscript
All Author List Richard J MacIsaac, George Jerums and Elif I Ekinci
Funding Agency and Grant Number
Funding Agency Grant Number
ADS-Sevier Research Grant to MacIsaac RJ
Corresponding author Richard J MacIsaac, Professor, BSc(HONS), PhD, MBBS, FRACP, Director, Department of Endocrinology and Diabetes, St Vincent’s Health, PO Box 2900, Fitzroy, Melbourne, Victoria 3065, Australia. r.macisaac@unimelb.edu.au
Keywords Diabetic nephropathy; Albuminuria; Glucose control; Glomerular filtration rate; Diabetes; Chronic kidney disease; Empagliflozin; Liraglutide; Semaglutide
Core Tip Tight glucose control has been clearly shown to reduce the incidence of micro- and macroalbuminuria. Evidence is now also emerging to suggest that intensive glucose control can slow glomerular filtration rate loss and possibly progression to end stage kidney disease. Furthermore, empagliflozin which is a glucose lowering agent of the sodium glucose like transporter-2 inhibitor class has been shown to have reno-protective effects over and above those expected from its glucose lowering effects alone. Recent clinical trials have also shown that Liraglutide and Semaglutide, injectable glucose lowering agents which are analogues of human glucagon like peptide-1, reduce progression to macroalbuminuria.
Publish Date 2017-05-15 10:13
Citation MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017; 8(5): 172-186
Url http://www.wjgnet.com/1948-9358/full/v8/i5/172
DOI http://dx.doi.org/10.4239/wjd.v8.i5.172
Full Article (PDF) WJD-8-172.pdf
Full Article (Word) WJD-8-172.doc
Manuscript File 29158-Review.docx
Answering Reviewers 29158-Answering reviewers.pdf
Audio Core Tip 29158-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 29158-Conflict-of-interest statement.pdf
Copyright License Agreement 29158-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 29158-Grant application form(s).pdf
Peer-review Report 29158-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 29158-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 29158-Scientific misconduct check.pdf
Scientific Editor Work List 29158-Scientific editor work list.pdf